Publication:
Expression of integrins αvß3 and αvß5 and their ligands in primary and secondary central nervous system neoplasms

Simple item page
dc.contributor.authorMittelbronn, Michel
dc.contributor.authorWarth, Arne
dc.contributor.authorMeyermann, Richard
dc.contributor.authorGoodman, Simon
dc.contributor.authorWeller, Michael
dc.date.accessioned2018-05-17T08:34:47Z
dc.date.available2018-05-17T08:34:47Z
dc.date.issued2013
dc.description.abstract. Aims: To study the expression of integrins αvß3 and αvß5 and their ligands in tumour, stroma and endothelial cells from human glioblastoma and CNS metastases from breast, lung and skin tumours. Methods and results: Integrin and integrin ligand expression was quantified in frozen tumour surgical specimens (15 glioblastomas and breast carcinoma metastases as well as 16 lung carcinoma and melanoma metastases) using immunohistochemistry. Gene expression profiles were evaluated in glioblastomas (n=424) and in normal brain (n=11). Overall, αvß3 expression was more common than αvß5, except in tumours derived from lung. αvß3 expression was most frequent in glioblastomas and melanoma metastases. Most lung-derived tumours expressed αvß5, but expression was less frequent in other tumours; about 20% of breast-derived tumours strongly expressed αvß5. Melanoma-derived tumours did not express αvß5. Expression of integrin ligands vitronectin, fibrinogen, fibronectin and osteopontin was variable between tumours, although most tumours expressed the ligands to some extent. Marked αvß3, but not αvß5, expression was common in stroma of CNS metastases. In blood vessels, αvß3 expression was more frequent than αvß5 and more pronounced in CNS metastases than in glioblastomas. Integrin ligand expression occurred in blood vessels in most tumours. In glioblastomas, mRNA expression of αvß3, αvß5, osteopontin and fibronectin were significantly upregulated over normal brain. Conclusions: Overall, we report distinct and heterogeneous patterns of integrin expression in primary and secondary brain tumours that may be relevant to the future development of integrintargeting therapeutic approaches to brain tumours.es
dc.formatapplication/pdfes
dc.format.extent10es
dc.identifier.citationHistology and Histopathology, vol. 28, nº 6, (2013)
dc.identifier.issn1699-5848
dc.identifier.issn0213-3911
dc.identifier.urihttp://hdl.handle.net/10201/58483
dc.languageenges
dc.publisherF. Hernández y Juan F. Madrid. Universidad de Murcia: Departamento de Biología Celular e Histologíaes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.subjectCanceres
dc.subjectIntegrin expressiones
dc.subject.otherCDU::6 - Ciencias aplicadas::61 - Medicinaes
dc.titleExpression of integrins αvß3 and αvß5 and their ligands in primary and secondary central nervous system neoplasmses
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Mittelbronn-28-749-758-2013.pdf
Size:
10.47 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
1.39 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Histology and histopathology Vol.28, nº 6 (2013)